Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes
- PMID: 49059
- PMCID: PMC432757
- DOI: 10.1073/pnas.72.6.2357
Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes
Abstract
The ability of thymus-derived lymphocytes (T cells) from BALB/c mice to recognize the individually specific antigenic determinants (idiotypes) of BALB/c myeloma proteins was tested. Spleen cells from donor mice immunized with a given myeloma protein greatly augmented the response of hapten-specific bone marrow-derived, thymus-independent lymphocytes (cells) to a hapten conjugate of the immunizing myeloma protein. This helper effect was specific for the myeloma protein idiotype; responses to hapten conjugates of similar myeloma proteins, bearing different idiotypic determinants, were not augmented by these spleen cells. That the helper cell is a T cell was shown by its marked sensitivity to cytolysis with an isoantiserum specific for T cells (anti-Thy-1-2) and complement. The discrimination between idiotypes by such T cells is roughly comparable to that of the antibody produced by the donors of the helper cells.
Similar articles
-
The role of thymus-derived lymphocytes in an antibody-mediated hapten-specific helper effect.Eur J Immunol. 1975 Jan;5(1):17-22. doi: 10.1002/eji.1830050105. Eur J Immunol. 1975. PMID: 1086213
-
Cell co-operation and hapten--carrier complexes.Immunology. 1975 Oct;29(4):675-85. Immunology. 1975. PMID: 52618 Free PMC article.
-
The immune response against hapten-autologous protein conjugates in the mouse.J Exp Med. 1973 Apr 1;137(4):911-31. doi: 10.1084/jem.137.4.911. J Exp Med. 1973. PMID: 4540327 Free PMC article.
-
Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.Immunol Rev. 1979;48:45-80. doi: 10.1111/j.1600-065x.1979.tb00298.x. Immunol Rev. 1979. PMID: 94898 Review. No abstract available.
-
Idiotypes as variable region markers: analogies between receptors on phosphorylcholine-specific T and B lymphocytes.Immunol Rev. 1977;34:3-33. doi: 10.1111/j.1600-065x.1977.tb00366.x. Immunol Rev. 1977. PMID: 322367 Review. No abstract available.
Cited by
-
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics.Transl Med Commun. 2021;6(1):18. doi: 10.1186/s41231-021-00097-y. Epub 2021 Aug 23. Transl Med Commun. 2021. PMID: 34458584 Free PMC article. Review.
-
Lymphoma Immunotherapy: Current Status.Front Immunol. 2015 Sep 1;6:448. doi: 10.3389/fimmu.2015.00448. eCollection 2015. Front Immunol. 2015. PMID: 26388871 Free PMC article. Review.
-
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells.Front Oncol. 2012 Oct 30;2:154. doi: 10.3389/fonc.2012.00154. eCollection 2012. Front Oncol. 2012. PMID: 23115759 Free PMC article.
-
Active immunotherapy: current state of the art in vaccine approaches for NHL.Curr Oncol Rep. 2012 Oct;14(5):433-40. doi: 10.1007/s11912-012-0255-7. Curr Oncol Rep. 2012. PMID: 22843515 Free PMC article. Review.
-
Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.Autoimmunity. 2012 Jun;45(4):320-31. doi: 10.3109/08916934.2012.659299. Epub 2012 Feb 23. Autoimmunity. 2012. PMID: 22288464 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources